Entera Bio Ltd.

Israël

Commandez votre montre hebdomadaire Entera Bio Ltd.
Quantité totale PI 47
Rang # Quantité totale PI 30 045
Note d'activité PI 2,5/5.0    36
Rang # Activité PI 20 845
Symbole boursier ENTX (nasdaq)
ISIN IL0011429839
Capitalisation 74.00M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

19 1
10 1
15 1
0
 
Dernier brevet 2025 - Methods and compositions for ora...
Premier brevet 2009 - Methods and compositions for ora...
Dernière marque 2024 - N-TAB
Première marque 2024 - N-TAB

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Methods and compositions for oral administration. This invention provides compositions comprisin...
2024 Invention Formulations for oral administration of active agents. A pharmaceutical composition for oral admi...
Invention Formulations comprising a combination of acid-neutralizing polymeric and non-polymeric substances...
Invention Formulations for oral administration of active agents. Pharmaceutical compositions comprising a ...
P/S Pharmaceutical preparations, namely, a drug delivery formulation that enables oral delivery of pr...
P/S pharmaceutical preparations, namely, drug delivery agents in the form of tablets that enable oral...
P/S Pharmaceutical preparations, namely, a drug delivery formulation that enables oral delivery of p...
Invention Formulations for oral administration of active agents. A pharmaceutical composition for oral adm...
Invention Treatment of hypoparathyroidism. A pharmaceutical composition for use in the treatment of hypopa...
2023 Invention Formulations comprising acid-neutralizing polymer for oral administration of glucagon-like peptid...
Invention Formulations comprising acid-neutralizing polymer for oral administration of active agents. A ph...
Invention Formulations comprising acid-neutralizing polymer for oral administration of parathyroid hormone....
Invention Formulations comprising acid-neutralizing polymer for oral administration of growth hormone. A ph...
Invention Formulations comprising acid-neutralizing polymer for oral administration of growth hormone-relea...
Invention Formulations comprising acid-neutralizing polymer for oral administration of kappa opioid recepto...
Invention Formulations comprising acid-neutralizing polymer for oral administration of active agents. A pha...
2022 Invention Methods and compositions for oral administration. This invention provides compositions comprising...
2017 Invention Formulations for oral administration of active agents. Pharmaceutical compositions comprising a t...
2016 Invention Formulations for oral administration of active agents with controlled absorption profile. A phar...
Invention Treatment of bone fractures and defects. A pharmaceutical composition for use in the treatment o...
Invention Treatment of osteoporosis. A pharmaceutical composition for use in the treatment of osteoporosis...
Invention Formulations for oral administration of active agents with controlled absorption profile. A pharm...
Invention Treatment of osteoporosis. A pharmaceutical composition for use in the treatment of osteoporosis ...
Invention Treatment of hypoparathyroidism. A pharmaceutical composition for use in the treatment of hypopar...
Invention Treatment of bone fractures and defects. A pharmaceutical composition for use in the treatment of...
2009 Invention Methods and compositions for oral administration of insulin. This invention provides compositions...
Invention Methods and compositions for oral administration of proteins.
This invention provides ...